Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Deep Vein Arterialization Post-Market Study

NCT03321552 is registered in ClinicalTrials.gov with LimFlow SA as lead sponsor.

NCT NCT03321552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03321552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Deep Vein Arterialization Post-Market Study
Lead sponsor
LimFlow SA
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2017
Completion date
January 23, 2025
Enrollment
34 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia